Company: AMTX
Filing Date: 2025-02-12
Form Type: 424B5
Source: 0001437749-25-003485
Chunk: 10

Company: AEMETIS, INC
Filing Date: 2025-02-12
Form: 424B5
Chunk 10
---
 |
| Nasdaq Global Market Symbol | AMTX                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Use of Proceeds             | We intend to use the net proceeds of this offering to upgrade our Keyes, California facility with energy efficiency projects; to fund engineering, permitting, construction and start-up of new projects; to construct additional dairy digesters along with the related pipeline, gas clean-up and pipeline interconnection facilities; to provide working capital; and to fund general corporate purposes. We may also use a portion of the net proceeds of this offering to repay certain indebtedness. See the section entitled “Use of Proceeds” on page S-12 of this prospectus supplement.                                                                                                                                                                                                                                                                                                                                                                                    |
| Risk Factors                | Investing in our common stock involves risks. You should carefully consider the risks described under “Risk Factors” in this prospectus supplement, in our most recent Annual Report on Form 10-K and our subsequent Quarterly Reports on Form 10-Q as well as the other information contained or incorporated by reference in this prospectus supplement and the accompanying base prospectus before making a decision to invest in our common stock.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |

<div align='center'>S-8

RISK FACTORS</div>

An investment in our securities involves a high degree of risk. Before deciding whether to invest in our securities, you should carefully consider the risks described below, together with the other information in this prospectus supplement and the accompanying base prospectus and the information contained in our other filings with the SEC as well as any amendment or update to our risk factors reflected in subsequent filings with the SEC, which are incorporated by reference in this prospectus supplement and the accompanying base prospectus in their entirety, together with other information in this prospectus supplement, the accompanying base prospectus, the information and documents incorporated by reference herein and therein, and in any free writing prospectus that we have authorized for use in connection with this offering. If any of these risks actually occurs, our business, financial condition, results of operations, or cash flow could be seriously harmed. This could cause the trading price of our securities to decline, resulting in a loss of all or part of your investment.

Risks Related to This Offering

You may experience immediate and substantial dilution.

The offering price per share in this offering may exceed the net tangible book value per share of our common stock. Assuming that an aggregate of 23,304,000 shares of our common stock are sold at a price of $2.11 per share pursuant to this prospectus supplement